Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A in severe restless legs syndrome
2009-011386-92Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in restless legs syndrome (RLS), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Investigator clinical global improvement response and Efficacy of botulinum toxin type A in severe restless legs syndrome. Started Apr 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2009-011386-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011386-92.